In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 170-176

  Jia, Wei Tao ^a   Luo, Shi Hua ^a   Zhang, Chang Qing ^a   Wang, Jian Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SULFATE; TEICOPLANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BONE REGENERATION; CHRONIC OSTEOMYELITIS; CONTROLLED STUDY; DEBRIDEMENT; DRUG EFFICACY; DRUG RELEASE; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; RABBIT; VENOUS BLOOD;

ANIMALS; ANTI-BACTERIAL AGENTS; BODY WEIGHT; CALCIUM SULFATE; DRUG DELIVERY SYSTEMS; INJECTIONS, INTRAVENOUS; LEUKOCYTE COUNT; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; RABBITS; STAPHYLOCOCCAL INFECTIONS; TEICOPLANIN; TIBIA;

EID: 73849139257     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01122-09     Document Type: Article

References (30)

1. Antoci, V., Jr., C. S. Adams, N. J. Hickok, I. M. Shapiro, and J. Parvizi. 2007. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin. Orthop. Relat. Res. 462:200-206.
2. Brogden, R. N., and D. H. Peters. 1994. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties therapeutic efficacy. Drugs 47:823-854.
3. Cepeda, J. A., T. Whitehouse, B. Cooper, J. Hails, K. Jones, F. Kwaku, L. Taylor, S. Hayman, S. Shaw, C. Kibbler, R. Shulman, M. Singer, and A. P. Wilson. 2004. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study. J. Antimicrob. Chemother. 53:345-355.
4. Chang, W., M. Colangeli, S. Colangeli, C. Di Bella, E. Gozzi, and D. Donati. 2007. Adult osteomyelitis: debridement versus debridement plus Osteoset T pellets. Acta Orthop. Belg. 73:238-243.
5. Courvalin, P. 2006. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42:S25-S34.
6. Dacquet, V., A. Varlet, R. N. Tandogan, M. M. Tahon, L. Fournier, F. Jehl, H. Monteil, and G. Bascoulergue. 1992. Antibiotic-impregnated plaster of Paris beads. Trials with teicoplanin. Clin. Orthop. Relat. Res. 282:241-249.
7. Gitelis, S., and G. T. Brebach. 2002. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J. Orthop. Surg. 10: 53-60.
8. Greenberg, R. N. 1990. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin. Antimicrob. Agents Chemother. 34:2392-2397.
9. Hanssen, A. D. 2005. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection. Clin. Orthop. Relat. Res. 437:91-96.
10. Heijink, A., M. Yaszemksi, R. Patel, M. Rouse, D. Lewallen, and A. Hanssen. 2006. Local antibiotic delivery with osteoset, DBx, and collagraft. Clin. Orthop. Relat. Res. 451:29-33.
11. Kandemir, O., V. Oztuna, M. Colak, A. Akdag., and H. Camdeviren. 2008. Comparison of the efficacy of tigecycline and teicoplanin in an experimental methicillin-resistant Staphylococcus aureus osteomyelitis model. J. Chemother. 20:53-57.
12. Karmarkar, M. G., E. S. Gershom, and P. R. Mehta. 2004. Enterococcal infections with special reference to phenotypic characterization and drug resistance. Indian J. Med. Res. 119:22-25.
13. LeFrock, J., and A. Ristuccia. 1999. Teicoplanin in the treatment of bone and joint infections: an open study. J. Infect. Chemother. 5:32-39.
14. Lew, D. P., and F. A. Waldvogel. 2004. Osteomyelitis. Lancet 364:369-379.
15. Mader, J. T., G. C. Landon, and J. Calhoun. 1993. Antimicrobial treatment of osteomyelitis. Clin. Orthop. Relat. Res. 295:87-95.
16. Marone, P., E. Concia, M. Andreoni, F. Suter, and M. Cruciani. 1990. Treatment of bone and soft tissue infections with teicoplanin. J. Antimicrob. Chemother. 25:435-459.
17. McKee, M. D., L. M. Wild, E. H. Schemitsch, and J. P. Waddell. 2002. The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial. J. Orthop. Trauma 16:622-627.
18. McLaren, A. C. 2004. Alternative materials to acrylic bone cement for delivery of depot antibiotics in orthopaedic infections. Clin. Orthop. Relat. Res. 427:101-106.
19. Murakami, K., W. Minamide, and K. Wada. 1991. Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction. J. Clin. Microbiol. 29:2240-2244.
20. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. NCCLS, Wayne, PA.
21. Nelson, C., S. McLaren, R. Skinner, M. Smeltzer, J. R. Thomas, and K. Olsen. 2002. The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J. Orthop. Res. 20:643-647.
22. Norden, C. W., R. L. Myerowitz, and E. Keleti. 1980. Experimental osteomyelitis due to Staphylococcus aureus or Pseudomonas aeruginosa: a radiographic-pathological correlative analysis. Br. J. Exp. Pathol. 61:451- 460.
23. Parsons, B., and E. Strauss. 2004. Surgical management of chronic osteomyelitis. Am. J. Surg. 188:57-66.
24. Sakoulas, G., and R. C. Moellering, Jr. 2008. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin. Infect. Dis. 46:S360-S367.
25. Smeltzer, M. S., J. R. Thomas, S. G. Hickmon, R. A. Skinner, C. L. Nelson, D. Griffith, T. R. Parr, Jr., and R. P. Evans. 1997. Characterization of a rabbit model of staphylococcal osteomyelitis. J. Orthop. Res. 15:414-421.
26. Thomas, M. V., D. A. Puleo, and M. Al-Sabbagh. 2005. Calcium sulfate: a review. J. Long Term Eff. Med. Implants 15:599-607.
27. Turner, T. M., R. M. Urban, S. Gitelis, K. N. Kuo, and G. B. Andersson. 2001. Radiographic and histologic assessment of calcium sulfate in experimental animal models and clinical use as a resorbable bone-graft substitute, a bone-graft expander, and a method for local antibiotic delivery. One institution's experience. J. Bone Joint Surg. Am. 83-A(Suppl. 2):8-18.
28. Wood, M. J. 2000. Comparative safety of teicoplanin and vancomycin. J. Chemother. 12:21-25.
29. Yenice, I., S. Calis, H. Kas, M. Ozalp, M. Ekizoglu, and A. Hincal. 2002. Biodegradable implantable teicoplanin beads for the treatment of bone infections. Int. J. Pharm. 242:271-275.
30. Ziglam, H. M., and R. G. Finch. 2001. Limitations of presently available glycopeptides in the treatment of Gram-positive infection. Clin. Microbiol. Infect. 7(Suppl. 4):53-65.